Cellceutix Provides Update to Shareholders

Cellceutix Corporation (OTCQB: CTIX), a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications today has provided an update to its shareholders.
http://bit.ly/1ohWoTU